Fortis Capital Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1,782
Closed -$328K – 187
2024
Q1
$328K Buy
+1,782
New +$339K 0.14% 130
2023
Q2
– Sell
-272
Closed -$45.8K – 494
2023
Q1
$45.8K Buy
272
+67
+33% +$12K 0.02% 291
2022
Q4
$34.7K Buy
+205
New +$37.2K 0.02% 337

Other funds holding RGEN

Fortis Capital Advisors's RGEN Position: Q2 2024 in Review

Fortis Capital Advisors sold out of Repligen (RGEN) in Q2 2024, closing a stake of 1,782 shares — an estimated $328K sold.

Fortis Capital Advisors first reported a position in RGEN in Q4 2022 and held it in 3 quarters. The position peaked at $328K in Q1 2024. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Fortis Capital Advisors reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Fortis Capital Advisors sold 1,782 Repligen shares in Q2 2024, an estimated $328K.
  • Fortis Capital Advisors first reported a position in Repligen in Q4 2022 and held it in 3 quarters.
  • Fortis Capital Advisors's Repligen position peaked at $328K in Q1 2024.
  • 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Fortis Capital Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.